Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Breakthrough Nausea and Vomiting”

4 trials

Showing 4 of 4 results

Testing effectiveness (Phase 2)Ended earlyNCT01031953
What this trial is testing

Fosaprepitant Dimeglumine in Treating Patients With Nausea and Vomiting Caused By Chemotherapy

Who this might be right for
Breakthrough Nausea and VomitingUnspecified Adult Solid Tumor, Protocol Specific
OHSU Knight Cancer Institute 34
Testing effectiveness (Phase 2)UnknownNCT06065722
What this trial is testing

Prevention of Breakthrough CINV in Patients Receiving Moderately or Highly Emetogenic Chemotherapy

Who this might be right for
Chemotherapy Induced Nausea and Vomiting
Simon Williamson Clinic 100
Testing effectiveness (Phase 2)WithdrawnNCT04085393
What this trial is testing

Granisetron Extended Release Injection (GERSC) for the Prevention of Chemotherapy-induced Nausea and Vomiting

Who this might be right for
Chemotherapy-induced Nausea and Vomiting
University of Alabama at Birmingham
Testing effectiveness (Phase 2)Study completedNCT01507194
What this trial is testing

Vestipitant (GW597599) in the Treatment of Breakthrough Postoperative Nausea and Vomiting (PONV)

Who this might be right for
Postoperative Nausea and Vomiting
Accenture 131

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation